Renewal of Michel Bouvier’s mandate as Chief Executive Officer of the IRIC

Following a meeting of the Executive Committee, held on June 12, the Université de Montréal announced the continuation of Michel Bouvier’s mandate as Chief Executive Officer of the IRIC for a second four-year term. Mr. Bouvier is a Full Professor in the Department of Biochemistry and Molecular Medicine of the Université de Montréal’s Faculty of […]

Thanks to the Blais Family Fund Golf Tournament, $70 000 was raised to support the research against cancer at the IRIC

More than 144 golfers gathered at the Buckingham Golf Club on July 6th for the Blais Family Fund Golf Tournament. $70 000 was raised to support the research against cancer at the IRIC. Pierre Blais, founder of the Blais Family Fund Golf Tournament, survived cancer thanks to an innovative procedure suggested by Dr. Sauvageau, Principal Investigator […]

UM171 Molecule: Completion of Phase I/II clinical trial for the treatment of blood cancer patients

On June 12, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal celebrated 10 years of activity for its medicinal chemistry core facility, the largest of its kind in a university setting in Canada. Today, the IRIC announces the completion of Phase I/II of the clinical trial testing the efficacy […]

When the gatekeeper drops its guard

By Martin Primeau Jean-Claude Labbé’s research team at the IRIC published a study that suggests why certain anti-cancer drugs have variable effectiveness depending on the type of cancer. The results of this research were recently published in the journal Molecular Biology of the Cell. The researchers were interested in a cellular quality-control system called “spindle […]

Krystel Vincent to participate in the Lindau Nobel Laureate Meeting in Germany

Krystel Vincent will participate in the 68th Lindau Nobel Laureate Meeting, which will take place from June 24 to 29 in Germany. Selected by the Scientific Examination Committee of the event’s Council, she received the distinction by virtue of the scope of her work carried out with Céline Laumont on identifying targets on cancer cells […]

Announcing the 2018 IRIC Next Generation Awards recipients

This summer, 18 students will have the chance this summer to conduct a research internship at the Institute, for 12 or 16 weeks and will receive an undergraduate research award, a value of $4,250 or $5,670. This opportunity is made possible thanks to 2018 IRIC Next Generation Awards, the financial contribution from a few of […]

Winners of the Réflexion Science IRIC 2018 contest

As part of the “Réflexion Science IRIC 2018” contest, close to 50 high-quality scientific artworks were submitted to the internal scientific promotion committee. Of this number, 8 were selected. Congratulations to the winners: Cédric Plutoni, Alizée Gouronnec, André Laperrière, Samuel Jacques, Chi-Yuan Yao, Lara Ellis, Camille de Jamblinne de Meux and Assya Trofimov.    The selected […]

The medicinal chemistry core facility celebrates 10 years of success at the IRIC

Relive the evening through photos.

$12M to support oncology research projects in Quebec – Announcing the Oncopole’s EMC2 competition winners

The Oncopole announced, as part of its first EMC2 competition, an investment of close to $12M to support seven oncology projects in Quebec. This investment is made possible thanks to an unprecedented collaboration with leading funders, notably the Cancer Research Society, the CQDM and IRICoR. Together, the partners managed to double the Oncopole’s initial budget, […]

AbbVie paving the way to developing a cancer vaccine

Montreal, June 5, 2018 – The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce that it has received funding support from AbbVie, a global research development-driven biopharmaceutical company, which will allow Dr. Claude Perreault, principal investigator working in the IRIC’s Immunobiology research unit and hematologist at […]

« Previous Page | Next Page »

Follow IRIC

Logo UdeM